submit news    HOME | FEEDBACK  


- Bio/Medicine

- Chemicals

- Defense

- Drug Delivery

- Education

- Electronics

- Energy

- Events

- Grants

- Industry

- Investment

- Litigation

- Materials


- Nanofabrication

- Nanoparticles

- Nanotubes

- Optics

- Partnership

- Patent

- Products

- Quantum dots

- Research

- Smart Dust

- Software

- Browse by Month

- Current Shows

- Previous Shows

- Submit Events

Become A Nanotechwire Partner

FEI Company

Veeco Instruments

Nano Science and Technology Institute

National Nanotechnology Initiative

Nanotechnology at Zyvex

Want to see your Company or Organization listed above? Become A Nanotechwire Partner Today - click here



Wednesday, July 02, 2008 | Bio/Medicine | 0 comments
Nanotechnology transforms an old, accidentally-discovered drug derived from mold
New oral angiogenesis inhibitor offers potential nontoxic therapy for a wide range of cancers

Tuesday, June 24, 2008 | Bio/Medicine | 0 comments
Laser Surgery Probe Targets Individual Cancer Cells
Mechanical engineering Assistant Professor Adela Ben-Yakar at The University of Texas at Austin has developed a laser "microscalpel" that destroys a single cell while leaving nearby cells intact, which could improve the precision of surgeries for cancer, epilepsy and other diseases.

Tuesday, June 24, 2008 | Bio/Medicine | 0 comments
New Data Demonstrates 5-FU Personalized Chemotherapy Management Assay Provides Similar Performance to More Complicated Liquid Chromatography
Data from a multicenter trial showed that a nanoparticle-based immunoassay from Saladax Biomedical, called 5-FU Personalized Chemotherapy Management (PCM), performed as well as high performance liquid chromatography (HPLC) or LC-MS/MS, but was easier to use, more rapid and more amenable to widespread clinical use

Thursday, June 19, 2008 | Bio/Medicine | 0 comments
Best code for disease detection, bar none
Malaria and dengue fever will be the early targets of new trans-Pacific research using minuscule "barcodes" to detect disease.

Monday, June 16, 2008 | Bio/Medicine | 0 comments
NanoViricides Anti-HIV Lead Drug Candidate Demonstrated Substantial Improvement in Survival Time in Animal Model
Results Better Than Combination Therapy in Double-Blind Animal Study

Sunday, June 15, 2008 | Bio/Medicine | 0 comments
Overcoming Drug Resistance - Nanoparticles Trigger Built-In Cell-Death Signal
Researchers have identified the major mechanisms that cancer cells use to neutralize the cytotoxic, or cell-killing, effects of anticancer drugs, and now they are using nanotechnology to help derail drug resistance and improve the odds of successfully treating cancer.

Sunday, June 15, 2008 | Bio/Medicine | 0 comments
Nanoparticle Delivers Antisense Agent to Tumors, Boosts Drug Effect in Resistant Tumors
A multifunctional drug delivery system consisting of a lipid-based nanoparticle, a standard anticancer drug, and a short nucleic acid designed to augment the activity of that drug has demonstrated the ability to treat drug-resistant tumor cells.

Sunday, June 15, 2008 | Bio/Medicine | 0 comments
Chemists Create Cancer-Detecting Nanoparticles
Scientists have found that magnetic nanoparticles can be especially helpful in locating cancerous cell clusters during MRI scans.

Sunday, June 15, 2008 | Bio/Medicine | 0 comments
Tumor Nanoparticles Trigger Pancreatic Cancer Cell Death
Using nanoparticles made from pieces of tumor cells, investigators from Aix-Marseille University in Marseille, France, have developed a new type of anticancer agent that appears to stop tumor cell growth and proliferation.

Sunday, June 15, 2008 | Bio/Medicine | 0 comments
Quantum Rods Probe Blood-Brain Barrier
Researchers from a NCI Cancer Nanotechnology Platform Partnership at the University of Buffalo have used targeted quantum rods both to breach the blood-brain barrier and to study how such constructs move across this largely impermeable barrier.

Friday, June 06, 2008 | Bio/Medicine | 0 comments
University of Queensland needle free vaccine delivery research recognised
Professor Kendall leads a research team at the Australian Institute for Bioengineering and Nanotechnology (AIBN) developing needle-free delivery of vaccines targeting the skin.

Monday, June 02, 2008 | Bio/Medicine | 0 comments
Calando Pharmaceuticals Doses First Patient in siRNA Phase I Clinical Trial
Calando Pharmaceuticals doses first patient with CALAA-01, a targeted nanoparticle therapeutic. This represents the first siRNA therapeutic to enter the clinic in oncology and the first targeted delivery of any RNAi product.

Monday, May 26, 2008 | Bio/Medicine | 0 comments
Dendrimers Improve Imaging With Magnetic Nanoparticles
Dendrimers are spherical polymer nanoparticles that have shown promise as targeted anticancer drug delivery vehicles. Iron oxide nanoparticles have already demonstrated the ability to image tumors and metastatic lesions. Now, researchers at the University of Michigan have combined the two, producing a layered nanoscale construct that targets and images tumors in animal models of human cancer.

Monday, May 26, 2008 | Bio/Medicine | 0 comments
Nanoparticle-Induced Heating Boosts Antitumor Radiation Therapy
A research team led by Sunil Krishnan, M.D., of the University of Texas M.D. Anderson Cancer Center, has found that pretreating tumors with gold nanoparticles and near-infrared radiation dramatically improves the response of tumors to radiation therapy.

Monday, May 26, 2008 | Bio/Medicine | 0 comments
Chip-Based Device Measures Drug Resistance in Tumor Cells
A team of investigators at Simon Fraser University in Burnaby, British Columbia, has developed a microfluidic chip that can trap individual cancer cells and investigate the ability of various pump-blocking drugs to overcome drug resistance.

More News: 

 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33 
 34  35  36  37  38  39  40  41  42  43  44  45  46  47 

- submit company
- submit news
- submit events
- advertise here

- More Events

Copyright 2017 | Privacy Policy |